What to expect from an antibody-drug conjugate for HR+/HER2- metastatic breast cancer
Everyday Health: Alberto Montero, professor at the School of Medicine, discussed the use of antibody-drug conjugates as a treatment method that appears to be more effective than traditional chemotherapy for slowing cancer progression and extending survival.